Intratumoral or Subcutaneous MK-2118, a Non-Cyclic Dinucleotide STING Agonist, with or Without Pembrolizumab for Advanced or Metastatic Solid Tumors or Lymphomas
Clinical cancer research an official journal of the American Association for Cancer Research（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined